Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allmed Group is a UK-headquartered renal care and medical device company focused on blood purification and haemodialysis solutions. The company designs, develops, manufactures, and distributes an end-to-end range of dialysis consumables, including haemodialysers, haemofilters, bloodline systems, HDF tubing sets, fluid purification products, and selected renal-support pharmaceuticals such as heparin and IV solutions. Allmed also markets the NIDUS infant haemodialysis system for babies and small children and offers OEM and bespoke extracorporeal product development and manufacturing services. The business operates internationally with R&D, manufacturing, and distribution capabilities across the EMEA region and commercial reach into Europe, the Middle East, South America, Africa, and other global markets. In June 2024, Alta Semper Capital acquired a controlling stake in the company to support capacity expansion, technology development, and broader access to dialysis solutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allmed Group.